Home
TOP INDUSTRY NEWS
-
Pfizer, US Gov’t in $5.29-Bn Pact for Oral COVID Drug
-
J&J Plans To Separate into Two Standalone Companies
-
US Gov’t Seeks More mRNA Vaccine Mfg Production
-
US Gov’t To Buy GSK’s/Vir’s COVID-19 Drug for $1 Bn
-
Supplier News: Hovione, Lonza, Arranta Bio & More
-
US Gov’t Takes More Action to Address Rx Drug Pricing
Features
-
Inside the New J&J and Consumer Health Company
J&J plans to separate its pharma and medical devices businesses into one company and its consumer health business into another company. What’s behind the new J&J?
-
Tracking Expansions in Biomanufacturing
CDMOs/CMOs are an integral part of bio/pharmaceutical companies’ manufacturing networks. A roundup of biomanufacturing expansion projects.
-
SPONSORED CONTENT
Feeling Pressure To Shorten Early Development Timelines?
-
SPONSORED CONTENT
Applications of Liquid-Filled Capsules for Challenging APIs in Pharmaceutical Manufacturing
-
SPONSORED CONTENT
Monoclonal Antibody Manufacturing for BioPharma: To Build or Outsource?
DCAT MEMBER COMPANY COMMUNITY
-
5 MINUTES WITH: Jim Miller, DCAT Research and Benchmarking Committee
DCAT Value Chain Insights’ “5 Minutes With,” part of the new DCAT Member Community section, features interviews with industry leaders on issues impacting the bio/pharmaceutical manufacturing value chain and other business…
-
Women Leaders in Pharma Interview: Fran Zipp, Lachman Consultant Services
The latest interview in the DCAT Alliance for Industry Women Committee’s Women Leaders in Pharma: An Interview Series features Frances (Fran) Zipp, President & CEO of Lachman Consultant Services, Inc.…
-
People on the Move
Here are the latest moves and promotions of employees of our DCAT Member Company community. To submit a request to be included in People on the Move, click here. From…
-
Women Leaders in Pharma Share Insights in Latest DCAT Webinar
On October 28, the DCAT Alliance for Industry Women Committee held a complimentary webinar titled “Lessons in Leadership: An Exclusive Live Chat with Women Leaders in Pharma.” During the hourlong…
